Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

651 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?
Altundag K, Altundag O, Baptista MZ, Turen S, Atik MA. Altundag K, et al. Among authors: altundag o. Osteoporos Int. 2005 Dec;16(12):2195-6. doi: 10.1007/s00198-005-2034-x. Osteoporos Int. 2005. PMID: 16273325 No abstract available.
Prognostic factors in breast cancer patients with brain metastases.
Harputluoglu H, Dizdar O, Altundag K. Harputluoglu H, et al. Among authors: altundag k. J Neurooncol. 2008 Apr;87(2):193. doi: 10.1007/s11060-007-9506-0. Epub 2007 Dec 14. J Neurooncol. 2008. PMID: 18080090 No abstract available.
Heparanase activity and bone loss in postmenopausal breast cancer patients.
Altundag K, Altundag O, Baptista MZ, Akyurek S. Altundag K, et al. Among authors: altundag o. J Clin Oncol. 2005 Dec 1;23(34):8916-7; author reply 8917-8. doi: 10.1200/JCO.2005.04.0121. J Clin Oncol. 2005. PMID: 16314656 No abstract available.
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.
Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K. Harputluoglu H, et al. Among authors: altundag k. J Natl Med Assoc. 2008 May;100(5):521-6. doi: 10.1016/s0027-9684(15)31298-0. J Natl Med Assoc. 2008. PMID: 18507204
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.
Dincer M, Altundag K, Harputluoglu H, Aksoy S, Cengiz M, Gullu I. Dincer M, et al. Among authors: altundag k. Med Oncol. 2008;25(3):356-9. doi: 10.1007/s12032-008-9045-3. Epub 2008 Jan 15. Med Oncol. 2008. PMID: 18196480
Triple-negative breast cancer and brain metastases.
Sait B, Cinar E, Altundag K. Sait B, et al. Among authors: altundag k. Clin Oncol (R Coll Radiol). 2010 Feb;22(1):84. doi: 10.1016/j.clon.2009.08.010. Epub 2009 Sep 13. Clin Oncol (R Coll Radiol). 2010. PMID: 19751969 No abstract available.
Statins may decrease skeletal-related events in breast cancer patients with bone metastases.
Dincer M, Bulut N, Harputluoglu H, Altundag K. Dincer M, et al. Among authors: altundag k. Med Hypotheses. 2006;67(5):1146-7. doi: 10.1016/j.mehy.2006.05.009. Epub 2006 Jul 17. Med Hypotheses. 2006. PMID: 16844315
Low bone mineral density value at the time of diagnosis of primary tumor in postmenopausal patients with operable breast cancer may increase bone metastasis risk.
Altundag K, Harputluoglu H, Bulut N. Altundag K, et al. Med Hypotheses. 2006;67(6):1465. doi: 10.1016/j.mehy.2006.05.026. Epub 2006 Jun 30. Med Hypotheses. 2006. PMID: 16814481 No abstract available.
Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases.
Harputluoglu H, Cengiz M, Altundag K. Harputluoglu H, et al. Among authors: altundag k. Radiother Oncol. 2007 Mar;82(3):356-7; author reply 357. doi: 10.1016/j.radonc.2006.10.019. Epub 2006 Nov 28. Radiother Oncol. 2007. PMID: 17126939 No abstract available.
Clinical and pathological characteristics of patients 80 years and older with breast cancer.
Tosur M, Sahin I, Ararat E, Babacan T, Altundag K. Tosur M, et al. Among authors: altundag k. J BUON. 2012 Apr-Jun;17(2):397-8. J BUON. 2012. PMID: 22740227 No abstract available.
651 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback